Company Filing History:
Years Active: 2013-2014
Title: Jaron Breitman: Innovator in Cardiac Technology
Introduction
Jaron Breitman is a notable inventor based in Timrat, Israel, recognized for his contributions to cardiac technology. With a total of 2 patents, he has developed innovative methods that enhance the functionality and safety of cardiac procedures.
Latest Patents
Breitman's latest patents include a method for the prevention of incorrect catheter rotation. This method involves providing an elongated probe capable of rotation about its longitudinal axis. The system automatically senses the rotation applied to the distal end of the probe and issues an alert to the operator if the rotation is in the second direction. This innovation aims to improve patient safety during catheterization procedures.
Another significant patent is the graphic interface for a multi-spine probe. This invention employs a cardiac catheter with multiple spines, each equipped with electrodes to map cardiac electrical activity. The system derives an electroanatomic map of the heart from the electrical signal data and presents it graphically. This allows for real-time adjustments to the locations and orientations of the spines, enhancing the precision of cardiac mapping.
Career Highlights
Throughout his career, Jaron Breitman has worked with prominent companies in the medical technology field, including Biosense Webster Ltd. and Biosense Webster, Inc. His work has significantly impacted the development of cardiac devices and procedures.
Collaborations
Breitman has collaborated with notable professionals in the field, including Matityahu Amit and Yoram Chmiel. These collaborations have contributed to the advancement of cardiac technology and the successful implementation of his inventions.
Conclusion
Jaron Breitman stands out as an innovative inventor in the realm of cardiac technology. His patents reflect a commitment to improving patient care and advancing medical procedures. His contributions continue to influence the field positively.